Eaton Vance Management Glaukos Corp Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $53,284 - $69,499	-1,202 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $17,799 - $25,189	442 Added 58.16%	1,202 $0
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $5,264 - $9,349	111 Added 17.1%	760 $0
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $12,785 - $17,097	175 Added 36.92%	649 $55,000
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $33,383 - $46,177	474 New	474 $40,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.